Skip to main content
Premium Trial:

Request an Annual Quote

Waters Enters into Agreement Increasing Revolving Facility by $200M

NEW YORK (GenomeWeb News) – Waters said today in a document filed with the US Securities and Exchange Commission that it entered into an Incremental Commitment Agreement to increase its revolving facility to $900 million from $700 million.

The Incremental Commitment Agreement is associated with a $1 billion credit agreement that Waters entered into with various lenders last year. The original agreement provided the company with a five-year, unsecured $300 million term loan facility and a $700 million revolving facility. The agreement allows Waters to request increases in commitments from lenders of no less than $25 million up to an aggregate additional amount of $250 million.

The term loan facility and the revolving facilities mature on July 28, 2016. JP Morgan Chase Bank was the administrative agent on the credit agreement, and JP Morgan Europe was the London agent.

The Scan

mRNA-Based Vaccine on the Way in China

China may soon have its own mRNA-based vaccine, according to Nature News.

Arranged Killing, Fraud Alleged by Prosecutors

The Wall Street Journal reports that prosecutors allege that the co-founder of a biotech arranged to have a business associate who threatened to expose him as a fraud killed.

Whirlwind Decade of CRISPR

The New York Times looks back at the 10 years since the University of California, Berkeley's Jennifer Doudna and her colleagues published their CRISPR paper.

PNAS Papers on Blue Cone Monochromacy Structural Variants, HIV-1 Mutant, T-ALL

In PNAS this week: structural variants linked to blue cone monochromacy, HIV-1 variants affecting the matrix protein p17, and more.